TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint The company reported that its Phase 3 CYPRESS study of ampreloxetine in patients with hypotension failed to meet its primary endpoint.
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million This healthcare firm runs a national network of surgical centers, specializing in outpatient procedures across key medical specialties.
Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround This fintech firm provides cloud-based digital banking solutions for U.S. financial institutions with a focus on subscription revenue.
Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year Integer Holdings delivers specialized medical devices and battery solutions to major healthcare OEMs worldwide.
Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters This cloud-based supply chain software provider serves retailers and distributors with automation and analytics solutions.
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
Irenic Dumps Most Papa John's Shares Papa John's International runs a global pizza network, earning revenue from both direct restaurant operations and franchise royalties.
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.
Here's Why Shares in Theravance Biopharma Exploded Today The company is making excellent progress on all its strategic goals.
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction Theravance Biopharma (TBPH) reported Q3 2025 results, beating EPS estimates with a profit of $0.04. Revenue was slightly below forecasts. Lead drug YUPELRI achieved record sales.
